)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals (500660) investor relations material
GlaxoSmithKline Pharmaceuticals Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary9 Feb, 2026
Executive summary
Achieved quarterly revenue of INR 1,023 crore, up 8.1% year-over-year, with strong growth in general medicines, specialty, and vaccines portfolios, and expanded specialty portfolio with new oncology assets and regulatory approvals.
Focused on innovation, digital engagement, and portfolio transformation, reaching 4 million omnichannel touchpoints and driving market share gains.
Standalone and consolidated unaudited financial results for the quarter and nine months ended 31st December 2025 were approved by the Board on 9th February 2026.
Leadership team with extensive experience in pharma and regional markets.
Financial highlights
EBITDA margin reached 35.9%, a 520 basis point improvement year-over-year, with EBITDA up 26.7% to ₹368 crore.
PAT margin increased to 27.3% (+290bps YoY), with PAT before exceptional items at ₹277 crore.
EPS for Q3 at ₹16.36, up 9% year-over-year.
Cash position remains robust at INR 2,426 crore.
Standalone and consolidated net profit and revenue grew year-over-year, with consolidated revenue at ₹104,126 lakhs and net profit at ₹27,228 lakhs.
Outlook and guidance
Strategic intent to double business over five years, targeting 12%-13% annual growth to reach INR 8,000 crore revenue.
Continued focus on scaling oncology, expanding adult immunization, and leveraging digital innovation for customer engagement.
Base business expected to deliver high single-digit growth, with specialty and vaccine launches providing additional momentum.
The company continues to monitor regulatory changes, especially regarding new labour codes, and will adjust accounting as needed.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next GlaxoSmithKline Pharmaceuticals earnings date
Q4 25/2615 May, 2026
GlaxoSmithKline Pharmaceuticals
Next GlaxoSmithKline Pharmaceuticals earnings date
Q4 25/2615 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
GlaxoSmithKline Pharmaceuticals Limited is an India-based pharmaceutical company engaged in the manufacturing, marketing, and distribution of prescription medicines and vaccines. The company operates across therapeutic areas such as respiratory, anti-infectives, dermatology, oncology, and vaccines. It is a subsidiary of GSK plc, a global biopharmaceutical company headquartered in the United Kingdom. GlaxoSmithKline Pharmaceuticals Limited serves healthcare professionals and institutions across India through a nationwide network. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage